VKTX Past Earnings image   This VKTX past earnings page last updated 4/18/2024
VKTX Past Earnings
PeriodPast Earnings DateGAAP
Q4 20232/7/2024-0.250
Q3 202310/25/2023-0.230
Q2 20237/26/2023-0.190
Q1 20234/26/2023-0.250
Q4 20222/8/2023-0.260
Q3 202210/26/2022-0.210
Q2 20227/27/2022-0.230
Q1 20224/27/2022-0.210
Q4 20212/9/2022-0.160
Q3 202111/3/2021-0.170
Q2 20217/28/2021-0.200
Q1 20214/28/2021-0.190
Q4 20202/17/2021-0.150
Q3 202010/28/2020-0.130
Q2 20207/29/2020-0.130
Q1 20204/30/2020-0.130
Q4 20192/26/2020-0.100
Q3 201911/5/2019-0.080
Q2 20198/1/2019-0.110
Q1 20195/2/2019-0.070
Q4 20183/13/2019-0.07
Q3 201811/7/2018-0.11
Q2 20188/9/2018-0.13
Q1 20185/9/2018-0.1
Q4 20173/7/2018-0.14
Q3 201711/8/2017-0.22
Q2 20178/9/2017-0.21
Q1 20175/10/2017-0.23
Q4 20163/21/2017-0.18
Q3 201611/10/2016-0.2
Q2 20168/10/2016-0.22
Q1 20165/10/2016-0.4
Q4 20153/8/2016-0.56
Q3 201511/5/2015-0.53
Q2 20158/13/2015-1.07
Q1 20156/12/2015-1.4
VKTX Past Revenue
PeriodPast Earnings DateGAAP
Q4 20232/7/2024NA
Q3 202310/25/2023NA
Q2 20237/26/2023NA
Q1 20234/26/2023NA
Q4 20222/8/2023NA
Q3 202210/26/2022NA
Q2 20227/27/2022NA
Q1 20224/27/2022NA
Q4 20212/9/2022NA
Q3 202111/3/2021NA
Q2 20217/28/2021NA
Q1 20214/28/2021NA
Q4 20202/17/2021NA
Q3 202010/28/2020NA
Q2 20207/29/2020NA
Q1 20204/30/2020NA
Q4 20192/26/2020NA
Q3 201911/5/2019NA
Q2 20198/1/2019NA
Q1 20195/2/2019NA
Q4 20183/13/2019NA
Q3 201811/7/2018NA
Q2 20188/9/2018NA
Q1 20185/9/2018NA
Q4 20173/7/2018NA
Q3 201711/8/2017NA
Q2 20178/9/2017NA
Q1 20175/10/2017NA
Q4 20163/21/2017NA
Q3 201611/10/2016NA
Q2 20168/10/2016NA
Q1 20165/10/2016NA
Q4 20153/8/2016NA
Q3 201511/5/2015NA
Q2 20158/13/2015NA
Q1 20156/12/2015NA
Quotes delayed 20 minutes

Email EnvelopeFree VKTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Viking Therapeutics (VKTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VLON Past Earnings
VNDA Past Earnings
VOR Past Earnings
VRAY Past Earnings
VRCA Past Earnings
VRDN Past Earnings
VREX Past Earnings
VRPX Past Earnings
VRTX Past Earnings
VSTM Past Earnings

VKTX Past Earnings Q&A

What was the best and worst VKTX past earnings results?
For Viking Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest VKTX past earnings result in our data set was -0.070/share posted in Q1 2019, while the lowest was in Q1 2015 when VKTX posted -1.4/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2023 when VKTX reported NA in revenue, while the quarter with the lowest revenue in our data set was Q4 2023 at NA of revenue.

  Suggested answer: There are 36 VKTX past earnings results in our data set.

On this page we presented the VKTX past earnings date information for Viking Therapeutics. Reviewing that VKTX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2019, when VKTX posted gaap of -0.070/share. Meanwhile the lowest VKTX past earnings result was in Q1 2015, when VKTX posted gaap of -1.4/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2023 when VKTX reported NA in revenue, while the smallest revenue quarter was Q4 2023 when VKTX reported NA in revenue.

Any self directed investor doing their due diligence on VKTX or any other given stock can benefit from researching all of the Viking Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Viking Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for VKTX. Thanks for visiting, and the next time you need to research VKTX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: FOA Insider Buying, BTU shares outstanding history, CERU Price Target.

 

VKTX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.